Alpha Wave Global, LP
Insider CIK 1558858 · APMD 10% owner · PACX Director, 10% owner · FRONU Director, 10% owner · ANRO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 720,655 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 5,404,918 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 0 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 1,351,227 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 4,006,611 | — | $0 | 5,542,476 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 1,001,651 | — | $0 | 1,001,651 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 534,214 | — | $0 | 1,535,865 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 1,512,480 | $13.50 | $20.42M | 7,054,956 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | — | — | — | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 5,404,918 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 720,655 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 1,351,227 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 1,512,480 | $13.50 | $20.42M | 7,054,956 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 4,006,611 | — | — | 5,542,476 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 534,214 | — | — | 1,535,865 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 1,001,651 | — | — | 1,001,651 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 1,144,763 | — | $0 | 0 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion deriv | 2024-02-06 | 2024-02-08 | 1,962,995 | — | $0 | 0 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion | 2024-02-06 | 2024-02-08 | 1,962,995 | — | $0 | 1,962,995 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | C Conversion | 2024-02-06 | 2024-02-08 | 1,144,762 | — | $0 | 3,107,757 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | P Buy | 2024-02-06 | 2024-02-08 | 600,000 | $16.00 | $9.60M | 3,707,757 | SEC↗ |
| FRONU Frontier Acquisition Corp. | D To issuer deriv | 2023-03-16 | 2023-03-20 | 120,000 | — | $0 | 0 | SEC↗ |
| FRONU Frontier Acquisition Corp. | D To issuer | 2023-03-16 | 2023-03-20 | 660,000 | — | $0 | 0 | SEC↗ |
| FRONU Frontier Acquisition Corp. | D To issuer | 2023-03-16 | 2023-03-20 | 2,400,000 | $10.20 | $24.48M | 0 | SEC↗ |
| PACX Pioneer Merger Corp. | D To issuer | 2023-01-17 | 2023-01-19 | 4,450,000 | $10.13 | $45.08M | 0 | SEC↗ |